Clinical Activity of Ipilimumab in Acral Melanoma: A Retrospective Review

BACKGROUND. Ipilimumab improves overall survival (OS) in advanced melanoma. Acral melanoma is an uncommon clinical subtype of this disease associated with poor prognosis. The clinical activity of ipilimumab has not been well-defined in advanced acral melanoma. METHODS. We retrospectively reviewed th...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncologist
Asıl Yazarlar: Johnson, Douglas B., Peng, Chengwei, Abramson, Richard G., Ye, Fei, Zhao, Shilin, Wolchok, Jedd D., Sosman, Jeffrey A., Carvajal, Richard D., Ariyan, Charlotte E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AlphaMed Press 2015
Konular:
Melanoma and Cutaneous Malignancies
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4571784/
https://ncbi.nlm.nih.gov/pubmed/25964307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0468
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller